Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1996-8-21
|
pubmed:abstractText |
In this report, the effect of macrophage inflammatory protein (MIP-1alpha) on the self-renewal, in vivo, of haemopoietic spleen colony-forming units (CFU-S) following cytotoxic damage, has been investigated. CFU-S recovery following injection of hydroxyurea, HU (1 g/kg at 0 and 7 hers) with or without MIP-1alpha intervention was measured over the following 5 days. In addition to the initial protection conferred by MIP-1alpha, the CFU-S population recovered about 1.7 times faster than in the unprotected controls. Direct measurement of the self-renewal capacity of the CFU-S population was made at 2 days after HU + MIP-1alpha treatment by measuring the number of CFU-S/spleen colony in a secondary transplant assay. CFU-S following HU treatment alone generated 60 CFU-S/colony. Additional MIP-1alpha treatment increased this to 90 CFU-S/colony. It is concluded that MIP-1alpha modifies the generation age structure of a regenerating CFU-S population such that recovery is initiated from the more primitive cells of the population's age spectrum and that this observation should extend the range of cytotoxic agents from which MIP-1alpha can give protection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL3,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL4,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyurea,
http://linkedlifedata.com/resource/pubmed/chemical/Macrophage Inflammatory Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Monokines
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0897-7194
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
145-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8679248-Animals,
pubmed-meshheading:8679248-Chemokine CCL3,
pubmed-meshheading:8679248-Chemokine CCL4,
pubmed-meshheading:8679248-Colony-Forming Units Assay,
pubmed-meshheading:8679248-Hematopoietic Stem Cells,
pubmed-meshheading:8679248-Hydroxyurea,
pubmed-meshheading:8679248-Macrophage Inflammatory Proteins,
pubmed-meshheading:8679248-Male,
pubmed-meshheading:8679248-Mice,
pubmed-meshheading:8679248-Mice, Inbred C57BL,
pubmed-meshheading:8679248-Mice, Inbred DBA,
pubmed-meshheading:8679248-Monokines,
pubmed-meshheading:8679248-Spleen
|
pubmed:year |
1995
|
pubmed:articleTitle |
MIP-1 alpha increases the self-renewal capacity of the hemopoietic spleen-colony-forming cells following hydroxyurea treatment in vivo.
|
pubmed:affiliation |
CRC Department of Experimental Haematology, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|